In 2020, Jin et al. reported that after receiving single-dose anti- PD-1 treatment combined with first-line chemotherapy, a patient with unresectable, MSI-H, locally advanced GC achieved complete pathological remission according to computed tomography and histopathology [66]. This evidence concerns the gene PDCD1 and gastric cancer.